Avanir Pharmaceuticals Announces Date Of Fiscal 2012 Third Quarter Financial Results And Conference Call

_{//health-fitness.news-articles.net/content/2012/ .. arter-financial-results-and-conference-call.html}
^{Published in Health and Fitness on Wednesday, August 1st 2012 at 5:47 GMT by Market Wire}  

Avanir Pharmaceuticals Announces Date Of Fiscal 2012 Third Quarter Financial Results... -- ALISO VIEJO, Calif., Aug. 1, 2012 /PRNewswire/ --

[ ]

My news for Investors

AtLeast one of the check box should be selected You are following news about Follow the latest news about AVNR

ALISO VIEJO, Calif., Aug. 1, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: [ AVNR ]) will report financial results for the quarter ended June 30, 2012, after market close on Wednesday August 8, 2012. The company will conduct a conference call and an audio webcast at 1:30 pm Pacific Time (4:30 pm Eastern Time) on the same day.

Conference Call Information:
Domestic callers: 1 (888) 396-2298
International callers: +1 (617) 847-8708
Passcode: 62935757

Webcast information: Visit [ http://www.avanir.com ].

A webcast replay will be available on the Avanir website for 30 days. A telephone replay will be available for 48 hours following the conclusion of the call by dialing 1 (888) 286-8010 for domestic callers, or +1 (617) 801-6888 for international callers, and entering reservation code 78768678.

About Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit [ www.avanir.com ].

AVANIR® is a trademark or registered trademark of Avanir Pharmaceuticals, Inc. in the United States and other countries.
©2012 Avanir Pharmaceuticals, Inc. All Rights Reserved.

SOURCE Avanir Pharmaceuticals, Inc.

RELATED LINKS
[ http://www.avanir.com ]